or Try an Advanced Search...

    Technical Analysis for SPRB - Spruce Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 0.75 -2.58% -0.02
    SPRB closed down 2.58 percent on Friday, May 17, 2024, on 38 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SPRB trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    20 DMA Support Bullish -2.58%
    Spinning Top Other -2.58%
    Gapped Down Weakness -2.58%
    Earnings Movers Other -9.07%
    Older End-of-Day Signals for SPRB ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 3 days ago
    Down 3% 3 days ago
    60 Minute Opening Range Breakdown 3 days ago
    Fell Below Previous Day's Low 3 days ago
    20 DMA Resistance 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    SPRB Chart by TradingView
    Basic chart:

    Profile

    Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Hyperplasia Endocrine Disorders Congenital Adrenal Hyperplasia Neurocrine Biosciences

    Is SPRB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Spruce Biosciences GAAP EPS of -$0.28 beats by $0.02, revenue of $2M beats by $0.84M
    May 13 Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates
    May 13 Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    May 1 Spruce Biosciences to Participate in May Investor Conferences
    Apr 30 Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
    Apr 22 Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
    Mar 27 Spruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should Know
    Mar 23 Revenue Downgrade: Here's What Analysts Forecast For Spruce Biosciences, Inc. (NASDAQ:SPRB)
    Mar 21 Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why
    Mar 16 Spruce Biosciences, Inc. (NASDAQ:SPRB) Just Reported Earnings, And Analysts Cut Their Target Price
    See more SPRB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.95
    52 Week Low 0.6711
    Average Volume 1,578,457
    200-Day Moving Average 2.12
    50-Day Moving Average 1.11
    20-Day Moving Average 0.76
    10-Day Moving Average 0.80
    Average True Range 0.07
    RSI (14) 33.77
    ADX 37.81
    +DI 17.65
    -DI 32.81
    Chandelier Exit (Long, 3 ATRs) 0.67
    Chandelier Exit (Short, 3 ATRs) 0.88
    Upper Bollinger Bands 0.86
    Lower Bollinger Band 0.65
    Percent B (%b) 0.47
    BandWidth 27.53
    MACD Line -0.10
    MACD Signal Line -0.15
    MACD Histogram 0.0509
    Fundamentals Value
    Market Cap 30.53 Million
    Num Shares 40.7 Million
    EPS -1.48
    Price-to-Earnings (P/E) Ratio -0.51
    Price-to-Sales 24.67
    Price-to-Book 1.90
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.80
    Resistance 3 (R3) 0.80 0.78 0.79
    Resistance 2 (R2) 0.78 0.77 0.78 0.79
    Resistance 1 (R1) 0.77 0.76 0.76 0.77 0.78
    Pivot Point 0.75 0.75 0.75 0.75 0.75
    Support 1 (S1) 0.74 0.74 0.73 0.73 0.72
    Support 2 (S2) 0.72 0.73 0.72 0.71
    Support 3 (S3) 0.71 0.72 0.71
    Support 4 (S4) 0.70